supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
Research Papers that Mention the Interaction
“In contrast, Mn added as Mn(III) was significantly more effective in inhibiting total cellular aconitase activity, and intact PC12 cells accumulated significantly more Mn when exposures occurred as Mn(III).”
Manganese oxidation state and its implications for toxicity.“ Brain manganese concentrations increased in a dose-dependent manner, with Mn(III) exposures producing significantly higher (> 25%) levels than exposures to Mn(II) but with no measurable differences in the accumulation of manganese across different brain regions.”
“Results indicate that Mn(III) exposures produced significantly higher blood manganese levels than equimolar exposures to Mn(II).”
Brain accumulation and toxicity of Mn(II) and Mn(III) exposures.“The capacity fade of lithium manganate-based cells is associated with the dissolution of Mn from cathode/electrolyte interface due to the disproportionation reaction of Mn(III) , and the subsequent deposition of Mn(II) on the anode.”
Effectively suppressing dissolution of manganese from spinel lithium manganate via a nanoscale surface-doping approach.“Therefore the content of Mn(III) in the birnessites decreases and the AOS of manganese increases.”
“We also show that the Mn(III)/Mn(II) reduction potentials are inappropriate predictors of P450-type activity of Mn porphyrin-catalyzed oxidations.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback